Brief: C4 Therapeutics Q3 EPS USD -0.35 Vs. IBES Estimate USD -0.38
31/10/2024 11:00
Oct 31 (Reuters) - C4 Therapeutics Q3 revenue USD 15.4 million vs. IBES estimate USD 4.6 million
CCCC — C4 Therapeutics News Story
0.000.00%
Last trade - 00:00- $376.46m
- $122.79m
- $35.95m